U.S. uses hundreds of Tomahawk missiles on Iran, alarming some at Pentagon

The U.S. military has fired more than 850 Tomahawk cruise missiles in four weeks against Iran, depleting inventory at a rate that has alarmed Pentagon officials. The burn rate has prompted internal discussions on replenishment and could pressure defense procurement, boost demand for missile suppliers, and trigger broader risk-off moves in markets sensitive to Middle East escalation.

Analysis

Rapid, high-rate consumption of precision cruise munitions exposes a brittle industrial base: many critical subsystems (navigation/seekers, RF components, precision machining and specialty propellants) have multi-month to multi-year lead times and limited qualified suppliers. Operational commanders will face binary choices — conserve stock for high-value targets or continue high-tempo strikes — which changes conflict pacing and forces substitution toward alternate standoff weapons, degrading mission sets in the near term.

Ramping production is a funding and capacity problem as much as an engineering one. Expect DoD to reprogram budgets or request supplemental appropriations within 30–90 days; however meaningful factory throughput increases typically take 6–18 months because of tooling, workforce certification and long-lead electronics. Second-order winners are likely to be niche subsystem suppliers and firms that can quickly convert existing lines; losers will be platform-centric contractors and programs deprioritized to free up dollars and shop-floor capacity.

Market pricing is likely to favor primes with existing missile lines, but execution risk is non-trivial — subcontract bottlenecks and supplier concentration cap near-term upside. Catalysts to watch: Congressional supplemental approval (accelerant), visible supply-chain awards/subcontracts (6–12 week signal), and diplomatic de-escalation (instant downside). Over a multi-year horizon, expect sustained shifts in procurement priorities toward surgeable munitions and domestic industrial-base rebuilding, benefiting recurring OEMs and select small-cap suppliers while compressing budgets for other modernization projects.

The consensus trade of “buy the primes” is directionally right but blunt. The market may be overpaying large-cap primes for a problem that will be resolved partly by emergency buys and allied transfers within months; conversely, it underestimates revenue upside for nimble subsystem vendors that can add shifts and capture OEM backlog. Positioning should be surgical: favor names with scalable fabs/lines and real backlog visibility rather than headline-driven defense exposure.

Key Decisions for Investors

• Long RTX (Raytheon Technologies) — 6–12 month hold. Buy shares or buy 12-month call spreads (e.g., buy Jan-2027 90C / sell Jan-2027 110C). Rationale: direct exposure to missile production and follow-on sustainment; upside ~15–30% if supplemental funding + order awards materialize, downside ~12–18% on rapid de-escalation or execution misses.
• Long LMT (Lockheed Martin) — 6–12 month hold. Buy shares or buy 9–12 month ITM calls to capture substitution demand (JASSM/related programs) and higher classified follow-ons. Expect asymmetric R/R: 12–25% upside on reorders; limited downside vs. market due to diversified business lines.
• Long select subsystem suppliers (examples: LHX, HEI) — 3–9 month trade via outright shares or short-dated calls. Focus on suppliers of guidance, RF and precision-machined components that can add shifts quickly; these often double-digit revenue growth with limited headline multiple compression if backlog is visible.
• Pair trade: Long RTX or LMT / Short GD (General Dynamics) — 6–12 months. Rationale: rotate from platform-heavy defense exposure into munition OEMs. Target a 2:1 notional tilt toward the long leg. Risk: broad defense bid re-rating or cross-cutting supplemental that benefits all primes will reduce spread.